{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:59:42Z","timestamp":1791021582087,"version":"4.1.0"},"reference-count":69,"publisher":"American Association for Cancer Research (AACR)","issue":"14","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vascular endothelial growth factor (VEGF) and interleukin-8\/CXCL8 (IL-8) are prominent pro-angiogenic and pro-metastatic proteins that represent negative prognostic factors in many types of cancer. Hypoxia is thought to be the primary environmental cause of VEGF and IL-8 expression in solid tumors. We hypothesized that a lack of nutrients other than oxygen could stimulate the expression of these factors and previously demonstrated that expression of VEGF and IL-8 is responsive to amino acid deprivation. In the present study, we examined the effect of glutamine availability on the expression of these factors as well as the role of transcription factors NF\u03baB and activating protein-1 (AP-1) in the response of TSE human breast carcinoma cells to glutamine deprivation. VEGF and IL-8 secretion and mRNA levels were dramatically induced by glutamine deprivation. mRNA stabilization contributed to this response. Glutamine deprivation increased NF\u03baB (p65\/p50) and AP-1 (Fra-1\/c-Jun+JunD) DNA-binding activities. Blocking NF\u03baB and AP-1 activation with curcumin as well as expression of dominant inhibitors, inhibitor of nuclear factor-\u03baB (I\u03baB) super repressor (I\u03baBM), and a mutant form of c-Fos (A-Fos) demonstrated that the activation of NF\u03baB and AP-1 transcription factors was necessary for the induction of IL-8 expression but dispensable for the induction of VEGF expression. A macro-array containing 111 NF\u03baB target genes identified a total of 17 that were up-regulated 2-fold or more in response to glutamine deprivation. These included growth regulated oncogene \u03b1 (GRO\u03b1\/GRO1\/CXCL1), another neutrophil chemoattractant implicated in tumor angiogenesis and metastasis.<\/jats:p>","DOI":"10.1158\/0008-5472.can-04-0682","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T22:41:30Z","timestamp":1127256090000},"page":"4858-4869","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Expression of Angiogenic Factors Vascular Endothelial Growth Factor and Interleukin-8\/CXCL8 Is Highly Responsive to Ambient Glutamine Availability"],"prefix":"10.1158","volume":"64","author":[{"given":"Ekaterina V.","family":"Bobrovnikova-Marjon","sequence":"first","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, University of New Mexico School of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Marjon","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, University of New Mexico School of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Barbash","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, University of New Mexico School of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Vander Jagt","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, University of New Mexico School of Medicine, and"},{"name":"2University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve F.","family":"Abcouwer","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, University of New Mexico School of Medicine, and"},{"name":"2University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2004,7,15]]},"reference":[{"key":"2022061620205763400_B1","doi-asserted-by":"crossref","unstructured":"McCarty MF, Liu W, Fan F, et al Promises and pitfalls of anti-angiogenic therapy in clinical trials. Trends Mol Med, 9:\u200853-8, \u20082003.","DOI":"10.1016\/S1471-4914(03)00002-9"},{"key":"2022061620205763400_B2","doi-asserted-by":"crossref","unstructured":"Shima DT, Deutsch U, D\u2019Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett, 370:\u2008203-8, \u20081995.","DOI":"10.1016\/0014-5793(95)00831-S"},{"key":"2022061620205763400_B3","doi-asserted-by":"crossref","unstructured":"Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem, 270:\u200819761-6, \u20081995.","DOI":"10.1074\/jbc.270.34.19761"},{"key":"2022061620205763400_B4","doi-asserted-by":"crossref","unstructured":"Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem, 270:\u200813333-40, \u20081995.","DOI":"10.1074\/jbc.270.22.13333"},{"key":"2022061620205763400_B5","doi-asserted-by":"crossref","unstructured":"Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev, 12:\u2008375-91, \u20082001.","DOI":"10.1016\/S1359-6101(01)00016-8"},{"key":"2022061620205763400_B6","doi-asserted-by":"crossref","unstructured":"De Larco JE, Wuertz BR, Rosner KA, et al A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol, 158:\u2008639-46, \u20082001.","DOI":"10.1016\/S0002-9440(10)64005-9"},{"key":"2022061620205763400_B7","unstructured":"Miller LJ, Kurtzman SH, Wang Y, Anderson KH, Lindquist RR, Kreutzer DL. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res, 18:\u200877-81, \u20081998."},{"key":"2022061620205763400_B8","unstructured":"Salcedo R, Martins-Green M, Gertz B, Oppenheim JJ, Murphy WJ. Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts. Clin Cancer Res, 8:\u20082655-65, \u20082002."},{"key":"2022061620205763400_B9","doi-asserted-by":"crossref","unstructured":"Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol, 170:\u20083369-76, \u20082003.","DOI":"10.4049\/jimmunol.170.6.3369"},{"key":"2022061620205763400_B10","doi-asserted-by":"crossref","unstructured":"Heidemann J, Ogawa H, Dwinell MB, et al Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem, 278:\u20088508-15, \u20082003.","DOI":"10.1074\/jbc.M208231200"},{"key":"2022061620205763400_B11","doi-asserted-by":"crossref","unstructured":"Benelli R, Morini M, Carrozzino F, et al Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation. FASEB J, 16:\u2008267-9, \u20082002.","DOI":"10.1096\/fj.01-0651fje"},{"key":"2022061620205763400_B12","doi-asserted-by":"crossref","unstructured":"Koch AE, Polverini PJ, Kunkel SL, et al Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science, 258:\u20081798-801, \u20081992.","DOI":"10.1126\/science.1281554"},{"key":"2022061620205763400_B13","doi-asserted-by":"crossref","unstructured":"Reiland J, Furcht LT, McCarthy JB. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate, 41:\u200878-88, \u20081999.","DOI":"10.1002\/(SICI)1097-0045(19991001)41:2<78::AID-PROS2>3.0.CO;2-P"},{"key":"2022061620205763400_B14","doi-asserted-by":"crossref","unstructured":"Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev, 12:\u2008375-91, \u20082001.","DOI":"10.1016\/S1359-6101(01)00016-8"},{"key":"2022061620205763400_B15","unstructured":"Roslin M, Henriksson R, Bergstrom P, Ungerstedt U, Bergenheim AT. Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol, 61:\u2008151-60, \u20082003."},{"key":"2022061620205763400_B16","doi-asserted-by":"crossref","unstructured":"Kallinowskil F, Davel S, Vaupell P, Baessler KH, Wagner K. Glucose, lactate, and ketone body utilization by human mammary carcinomas in vivo. Adv Exp Med Biol, 191:\u2008763-73, \u20081985.","DOI":"10.1007\/978-1-4684-3291-6_77"},{"key":"2022061620205763400_B17","doi-asserted-by":"crossref","unstructured":"Stein I, Neeman M, Shweiki D, Itin A, Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol, 15:\u20085363-8, \u20081995.","DOI":"10.1128\/MCB.15.10.5363"},{"key":"2022061620205763400_B18","doi-asserted-by":"crossref","unstructured":"Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA, 92:\u2008768-72, \u20081995.","DOI":"10.1073\/pnas.92.3.768"},{"key":"2022061620205763400_B19","doi-asserted-by":"crossref","unstructured":"Collins CL, Wasa M, Souba WW, Abcouwer SF. Regulation of glutamine synthetase in human breast carcinoma cells and experimental tumors. Surgery, 122:\u2008451-63, \u20081997.","DOI":"10.1016\/S0039-6060(97)90039-8"},{"key":"2022061620205763400_B20","doi-asserted-by":"crossref","unstructured":"Marjon PL, Bobrovnikova-Marjon EV, Abcouwer SF. Expression of the proangiogenic factors vascular endothelial growth factor and interleukin-8\/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress. Mol Cancer, 3:\u20084\u20082004.","DOI":"10.1158\/0008-5472.CAN-04-0682"},{"key":"2022061620205763400_B21","unstructured":"Abcouwer SF, Marjon PL, Loper RK, Vander Jagt DL. Response of VEGF expression to amino acid deprivation and inducers of endoplasmic reticulum stress. Investig Ophthalmol Vis Sci, 43:\u20082791-8, \u20082002."},{"key":"2022061620205763400_B22","doi-asserted-by":"crossref","unstructured":"Roebuck KA. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res, 19:\u2008429-38, \u20081999.","DOI":"10.1089\/107999099313866"},{"key":"2022061620205763400_B23","doi-asserted-by":"crossref","unstructured":"Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-\u03baB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis, 177:\u20081275-81, \u20081998.","DOI":"10.1086\/515279"},{"key":"2022061620205763400_B24","doi-asserted-by":"crossref","unstructured":"Huang S, DeGuzman A, Bucana CD, Fidler IJ. Level of interleukin-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-\u03baB activity. Cytokines Cell Mol Ther, 6:\u20089-17, \u20082000.","DOI":"10.1080\/13684730050515868"},{"key":"2022061620205763400_B25","doi-asserted-by":"crossref","unstructured":"Takaya H, Andoh A, Shimada M, Hata K, Fujiyama Y, Bamba T. The expression of chemokine genes correlates with nuclear factor-\u03baB activation in human pancreatic cancer cell lines. Pancreas, 21:\u200832-40, \u20082000.","DOI":"10.1097\/00006676-200007000-00049"},{"key":"2022061620205763400_B26","unstructured":"Bancroft CC, Chen Z, Dong G, et al Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-\u03baB signal pathways. Clin Cancer Res, 7:\u2008435-42, \u20082001."},{"key":"2022061620205763400_B27","doi-asserted-by":"crossref","unstructured":"Chua CC, Hamdy RC, Chua BH. Mechanism of transforming growth factor-\u03b21-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3\u2013E1 cells. Biochim Biophys Acta, 1497:\u200869-76, \u20082000.","DOI":"10.1016\/S0167-4889(00)00040-9"},{"key":"2022061620205763400_B28","doi-asserted-by":"crossref","unstructured":"Yoshida S, Ono M, Shono T, et al Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor \u03b1-dependent angiogenesis. Mol Cell Biol, 17:\u20084015-23, \u20081997.","DOI":"10.1128\/MCB.17.7.4015"},{"key":"2022061620205763400_B29","doi-asserted-by":"crossref","unstructured":"Eisma RJ, Spiro JD, Kreutzer DL. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma. Laryngoscope, 109:\u2008687-93, \u20081999.","DOI":"10.1097\/00005537-199905000-00002"},{"key":"2022061620205763400_B30","doi-asserted-by":"crossref","unstructured":"Fasciani A, D\u2019Ambrogio G, Bocci G, Monti M, Genazzani AR, Artini PG. High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata. Mol Hum Reprod, 6:\u200850-4, \u20082000.","DOI":"10.1093\/molehr\/6.1.50"},{"key":"2022061620205763400_B31","unstructured":"Bancroft CC, Chen Z, Dong G, et al Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-\u03baB signal pathways. Clin Cancer Res, 7:\u2008435-42, \u20082001."},{"key":"2022061620205763400_B32","doi-asserted-by":"crossref","unstructured":"Yuan A, Yu CJ, Luh KT, Kuo SH, Lee YC, Yang PC. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. J Clin Oncol, 20:\u2008900-10, \u20082002.","DOI":"10.1200\/JCO.2002.20.4.900"},{"key":"2022061620205763400_B33","doi-asserted-by":"crossref","unstructured":"Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ. Blockade of NF-\u03baB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene, 20:\u20084188-97, \u20082001.","DOI":"10.1038\/sj.onc.1204535"},{"key":"2022061620205763400_B34","unstructured":"Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ. Blockade of nuclear factor-\u03baB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res, 60:\u20085334-9, \u20082000."},{"key":"2022061620205763400_B35","doi-asserted-by":"crossref","unstructured":"Shi Q, Le X, Abbruzzese JL, et al Cooperation between transcription factor AP-1 and NF-\u03baB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia. J Interferon Cytokine Res, 19:\u20081363-71, \u20081999.","DOI":"10.1089\/107999099312821"},{"key":"2022061620205763400_B36","doi-asserted-by":"crossref","unstructured":"Collins TS, Lee LF, Ting JP. Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-\u03baB- and AP-1-dependent mechanism. Cancer Immunol Immunother, 49:\u200878-84, \u20082000.","DOI":"10.1007\/s002620050605"},{"key":"2022061620205763400_B37","doi-asserted-by":"crossref","unstructured":"Desbaillets I, Diserens AC, de Tribolet N, Hamou MF, Van Meir EG. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene, 18:\u20081447-56, \u20081999.","DOI":"10.1038\/sj.onc.1202424"},{"key":"2022061620205763400_B38","doi-asserted-by":"crossref","unstructured":"Damert A, Ikeda E, Risau W. Activator-protein-1 binding potentiates the hypoxiainduciblefactor-1-mediated hypoxia-induced transcriptional activation of vascularendothelial growth factor expression in C6 glioma cells. Biochem J, 327:\u2008419-23, \u20081997.","DOI":"10.1042\/bj3270419"},{"key":"2022061620205763400_B39","doi-asserted-by":"crossref","unstructured":"Xu L, Fukumura D, Jain RK. Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1\/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem, 277:\u200811368-74, \u20082002.","DOI":"10.1074\/jbc.M108347200"},{"key":"2022061620205763400_B40","doi-asserted-by":"crossref","unstructured":"Shih SC, Claffey KP. Role of AP-1 and HIF-1 transcription factors in TGF-\u03b2 activation of VEGF expression. Growth Factors, 19:\u200819-34, \u20082001.","DOI":"10.3109\/08977190109001073"},{"key":"2022061620205763400_B41","doi-asserted-by":"crossref","unstructured":"Michiels C, Minet E, Michel G, Mottet D, Piret JP, Raes M. HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of MAP kinases. IUBMB Life, 52:\u200849-53, \u20082001.","DOI":"10.1080\/15216540252774766"},{"key":"2022061620205763400_B42","doi-asserted-by":"crossref","unstructured":"Jiang HY, Wek SA, McGrath BC, et al Phosphorylation of the \u03b1 subunit of eukaryotic initiation factor 2 is required for activation of NF-\u03baB in response to diverse cellular stresses. Mol Cell Biol, 23:\u20085651-63, \u20082003.","DOI":"10.1128\/MCB.23.16.5651-5663.2003"},{"key":"2022061620205763400_B43","doi-asserted-by":"crossref","unstructured":"Olive M, Krylov D, Echlin DR, Gardner K, Taparowsky E, Vinson C. A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J Biol Chem, 272:\u200818586-94, \u20081997.","DOI":"10.1074\/jbc.272.30.18586"},{"key":"2022061620205763400_B44","doi-asserted-by":"crossref","unstructured":"Chomcynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162:\u2008156-9, \u20081987.","DOI":"10.1016\/0003-2697(87)90021-2"},{"key":"2022061620205763400_B45","doi-asserted-by":"crossref","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA, 95:\u20082509-14, \u20081998.","DOI":"10.1073\/pnas.95.5.2509"},{"key":"2022061620205763400_B46","doi-asserted-by":"crossref","unstructured":"Abcouwer SF, Schwarz C, Meguid RA. Glutamine deprivation induces the expression of GADD45 and GADD153 primarily by mRNA stabilization. J Biol Chem, 274:\u200828645-51, \u20081999.","DOI":"10.1074\/jbc.274.40.28645"},{"key":"2022061620205763400_B47","doi-asserted-by":"crossref","unstructured":"Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem, 271:\u20082746-53, \u20081996.","DOI":"10.1074\/jbc.271.5.2746"},{"key":"2022061620205763400_B48","doi-asserted-by":"crossref","unstructured":"Park S, Lee DK, Yang CH. Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells. Cancer Lett, 127:\u200823-8, \u20081998.","DOI":"10.1016\/S0304-3835(97)00543-0"},{"key":"2022061620205763400_B49","doi-asserted-by":"crossref","unstructured":"Jobin C, Bradham CA, Russo MP, et al Curcumin blocks cytokine-mediated NF-\u03baB activation and proinflammatory gene expression by inhibiting inhibitory factor I-\u03baB kinase activity. J Immunol, 163:\u20083474-83, \u20081999.","DOI":"10.4049\/jimmunol.163.6.3474"},{"key":"2022061620205763400_B50","unstructured":"Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC. Curcumin inhibits IL1 \u03b1 and TNF-\u03b1 induction of AP-1 and NF-\u03baB DNA binding activity in bone marrow stromal cells. Hematopathol Mol Hematol, 11:\u200849-62, \u20081997."},{"key":"2022061620205763400_B51","doi-asserted-by":"crossref","unstructured":"Bierhaus A, Zhang Y, Quehenberger P, et al The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-\u03ba B. Thromb Haemostasis, 77:\u2008772-82, \u20081997.","DOI":"10.1055\/s-0038-1656049"},{"key":"2022061620205763400_B52","doi-asserted-by":"crossref","unstructured":"Feig BW, Lu X, Hunt KK, et al Inhibition of the transcription factor nuclear factor-\u03ba B by adenoviral-mediated expression of I \u03ba B \u03b1 M results in tumor cell death. Surgery, 126:\u2008399-405, \u20081999.","DOI":"10.1016\/S0039-6060(99)70184-4"},{"key":"2022061620205763400_B53","doi-asserted-by":"crossref","unstructured":"Salnikow K, Kluz T, Costa M, et al The regulation of hypoxic genes by calcium involves c-Jun\/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol Cell Biol, 22:\u20081734-41, \u20082002.","DOI":"10.1128\/MCB.22.6.1734-1741.2002"},{"key":"2022061620205763400_B54","doi-asserted-by":"crossref","unstructured":"de Beaux AC, O\u2019Riordain MG, Ross JA, Jodozi L, Carter DC, Fearon KC. Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Nutrition, 14:\u2008261-5, \u20081998.","DOI":"10.1016\/S0899-9007(97)00477-2"},{"key":"2022061620205763400_B55","doi-asserted-by":"crossref","unstructured":"Lin MT, Saito H, Furukawa S, et al Alanyl-glutamine enriched total parenteral nutrition improves local, systemic, and remote organ responses to intraperitoneal bacterial challenge. J Parenter Enteral Nutr, 25:\u2008346-51, \u20082001.","DOI":"10.1177\/0148607101025006346"},{"key":"2022061620205763400_B56","doi-asserted-by":"crossref","unstructured":"Huang Y, Li N, Liboni K, Neu J. Glutamine decreases lipopolysaccharide-induced IL-8 production in Caco-2 cells through a non-NF-\u03baB p50 mechanism. Cytokine, 22:\u200877-83, \u20082003.","DOI":"10.1016\/S1043-4666(03)00115-7"},{"key":"2022061620205763400_B57","doi-asserted-by":"crossref","unstructured":"Coeffier M, Marion R, Ducrotte P, Dechelotte P. Modulating effect of glutamine on IL-1\u03b2-induced cytokine production by human gut. Clin Nutr, 22:\u2008407-13, \u20082003.","DOI":"10.1016\/S0261-5614(03)00040-2"},{"key":"2022061620205763400_B58","doi-asserted-by":"crossref","unstructured":"Williams BR. PKR: a sentinel kinase for cellular stress. Oncogene, 18:\u20086112-20, \u20081999.","DOI":"10.1038\/sj.onc.1203127"},{"key":"2022061620205763400_B59","doi-asserted-by":"crossref","unstructured":"Rhoads JM, Argenzio RA, Chen W, et al l-Glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol, 272:\u2008G943-53, \u20081997.","DOI":"10.1152\/ajpgi.1997.272.5.G943"},{"key":"2022061620205763400_B60","doi-asserted-by":"crossref","unstructured":"Roybal CN, Yang S, Sun CW, et al Homocysteine increases the expression of VEGF by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem, 279:\u200814844-52, \u20082004.","DOI":"10.1074\/jbc.M312948200"},{"key":"2022061620205763400_B61","doi-asserted-by":"crossref","unstructured":"Huang S, DeGuzman A, Bucana CD, Fidler IJ. Nuclear factor-\u03baB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin Cancer Res, 6:\u20082573-81, \u20082000.","DOI":"10.1080\/13684730050515868"},{"key":"2022061620205763400_B62","doi-asserted-by":"crossref","unstructured":"Bancroft CC, Chen Z, Yeh J, et al Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-\u03baB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer, 99:\u2008538-48, \u20082002.","DOI":"10.1002\/ijc.10398"},{"key":"2022061620205763400_B63","doi-asserted-by":"crossref","unstructured":"Lee TH, Avraham H, Lee SH, Avraham S. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J Biol Chem, 277:\u200810445-51, \u20082002.","DOI":"10.1074\/jbc.M107348200"},{"key":"2022061620205763400_B64","doi-asserted-by":"crossref","unstructured":"Loukinova E, Chen Z, Van Waes C, Dong G. Expression of proangiogenic chemokine Gro 1 in low and high metastatic variants of Pam murine squamous cell carcinoma is differentially regulated by IL-1\u03b1, EGF and TGF-\u03b21 through NF-\u03baB dependent and independent mechanisms. Int J Cancer, 94:\u2008637-44, \u20082001.","DOI":"10.1002\/ijc.1514"},{"key":"2022061620205763400_B65","doi-asserted-by":"crossref","unstructured":"Lane BR, Liu J, Bock PJ, et al Interleukin-8 and growth-regulated oncogene \u03b1 mediate angiogenesis in Kaposi\u2019s sarcoma. J Virol, 76:\u200811570-83, \u20082002.","DOI":"10.1128\/JVI.76.22.11570-11583.2002"},{"key":"2022061620205763400_B66","doi-asserted-by":"crossref","unstructured":"Loukinova E, Dong G, Enamorado-Ayalya I, et al Growth regulated oncogene-\u03b1 expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene, 19:\u20083477-86, \u20082000.","DOI":"10.1038\/sj.onc.1203687"},{"key":"2022061620205763400_B67","doi-asserted-by":"crossref","unstructured":"Moore BB, Arenberg DA, Stoy K, et al Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol, 154:\u20081503-12, \u20081999.","DOI":"10.1016\/S0002-9440(10)65404-1"},{"key":"2022061620205763400_B68","doi-asserted-by":"crossref","unstructured":"Youngs SJ, Ali SA, Taub DD, Rees RC. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer, 71:\u2008257-66, \u20081997.","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D"},{"key":"2022061620205763400_B69","unstructured":"Fuchs IB, Lichtenegger W, Buehler H, et al The prognostic significance of epithelial-mesenchymal transition in breast cancer. Anticancer Res, 22:\u20083415-9, \u20082002."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/14\/4858\/2516317\/zch01404004858.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/14\/4858\/2516317\/zch01404004858.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T17:26:03Z","timestamp":1683221163000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/64\/14\/4858\/511486\/Expression-of-Angiogenic-Factors-Vascular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,15]]},"references-count":69,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2004,7,15]]},"published-print":{"date-parts":[[2004,7,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-04-0682","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,15]]}}}